A patient with regressing atypical histiocytosis running a far from benign course.
We describe a case of regressing atypical histiocytosis (RAH) which showed evidence of aggressive local disease and systemic involvement. Both the local response of this patient to low dose radiotherapy and the systemic response to combination chemotherapy were clinically complete and rapidly achieved.
Morgan
J S
JS
Department of Clinical Oncology, Velindre Hospital, Whitchurch, Cardiff, UK.
Levay
J
J
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D054747:Histiocytic Sarcoma / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D006801:Humans